These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty. Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823 [TBL] [Abstract][Full Text] [Related]
5. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. Gillette BP; Maradit Kremers H; Duncan CM; Smith HM; Trousdale RT; Pagnano MW; Sierra RJ J Arthroplasty; 2013 Sep; 28(8 Suppl):137-9. PubMed ID: 23886409 [TBL] [Abstract][Full Text] [Related]
6. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. Tuttle JR; Ritterman SA; Cassidy DB; Anazonwu WA; Froehlich JA; Rubin LE J Arthroplasty; 2014 Aug; 29(8):1512-5. PubMed ID: 24630599 [TBL] [Abstract][Full Text] [Related]
7. Do we really need to routinely crossmatch blood before primary total knee or hip arthroplasty? Mundy GM; Hardiment K; Revill J; Birtwistle SJ; Power RA Acta Orthop Scand; 2004 Oct; 75(5):567-72. PubMed ID: 15513488 [TBL] [Abstract][Full Text] [Related]
8. Blood utilization in hip and knee arthroplasty: a cost-minimization study. Gower A; Hussein AI; Briggs PJ; Dewar MS J R Coll Surg Edinb; 1998 Dec; 43(6):397-9. PubMed ID: 9990787 [TBL] [Abstract][Full Text] [Related]
9. Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. Moskal JT; Harris RN; Capps SG J Arthroplasty; 2015 Mar; 30(3):365-8. PubMed ID: 25458093 [TBL] [Abstract][Full Text] [Related]
10. The High Value Healthcare Collaborative: Observational Analyses of Care Episodes for Hip and Knee Arthroplasty Surgery. Weeks WB; Schoellkopf WJ; Sorensen LS; Masica AL; Nesse RE; Weinstein JN J Arthroplasty; 2017 Mar; 32(3):702-708. PubMed ID: 27776908 [TBL] [Abstract][Full Text] [Related]
11. Red blood cell transfusions for elective hip and knee arthroplasty: opportunity to improve quality of care and documentation. Cook SS; Cangialose CB; Sieburg DM; Kieszak SM; Boudreau R; Hoffman LH; Elward KS; Ballard DJ Clin Perform Qual Health Care; 1999; 7(1):5-16. PubMed ID: 10351595 [TBL] [Abstract][Full Text] [Related]
12. Audit on the efficient use of cross-matched blood in elective total hip and total knee replacement. Rogers BA; Johnstone DJ Ann R Coll Surg Engl; 2006 Mar; 88(2):199-201. PubMed ID: 16551419 [TBL] [Abstract][Full Text] [Related]
13. Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty. Kopanidis P; Hardidge A; McNicol L; Tay S; McCall P; Weinberg L J Orthop Surg Res; 2016 Feb; 11():28. PubMed ID: 26927608 [TBL] [Abstract][Full Text] [Related]
14. Are Preoperative Serologic Type and Screen Tests Necessary for Primary Total Joint Arthroplasty Patients in Specialty Surgical Hospitals? Tischler EH; Chen AF; Matthews CN; Arnold WV; Smith EB J Arthroplasty; 2016 Nov; 31(11):2442-2446. PubMed ID: 27237967 [TBL] [Abstract][Full Text] [Related]
15. Maximum surgical blood ordering schedule in a district general hospital saves money and resources. Richardson NG; Bradley WN; Donaldson DR; O'Shaughnessy DF Ann R Coll Surg Engl; 1998 Jul; 80(4):262-5. PubMed ID: 9771226 [TBL] [Abstract][Full Text] [Related]
16. Analysis of blood transfusion predictors in patients undergoing elective oesophagectomy for cancer. Ayantunde AA; Ng MY; Pal S; Welch NT; Parsons SL BMC Surg; 2008 Jan; 8():3. PubMed ID: 18221510 [TBL] [Abstract][Full Text] [Related]
17. An audit of perioperative blood transfusions in a regional hospital to rationalise a maximum surgical blood ordering schedule. Blank RM; Blank SP; Roberts HE Anaesth Intensive Care; 2018 Sep; 46(5):498-503. PubMed ID: 30189824 [TBL] [Abstract][Full Text] [Related]
18. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Martinez V; Monsaingeon-Lion A; Cherif K; Judet T; Chauvin M; Fletcher D Br J Anaesth; 2007 Dec; 99(6):794-800. PubMed ID: 17928302 [TBL] [Abstract][Full Text] [Related]
19. Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. Scardino M; Martorelli F; D'Amato T; Fenocchio G; Simili V; Grappiolo G; Di Matteo B; Kon E; Lagioia M Int Orthop; 2019 Dec; 43(12):2707-2714. PubMed ID: 30671601 [TBL] [Abstract][Full Text] [Related]
20. Direct hospital cost determinants following hip and knee arthroplasty. Peel TN; Cheng AC; Liew D; Buising KL; Lisik J; Carroll KA; Choong PF; Dowsey MM Arthritis Care Res (Hoboken); 2015 May; 67(6):782-90. PubMed ID: 25470687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]